1. RetinAI

    0 Comments Leave a Comment

    1-5 of 5
    1. Mentioned In 5 Articles

    2. Validation Study of RETINA-AI Galaxy™, an Automated Diabetic Retinopathy Screening Device

      Validation Study of RETINA-AI Galaxy™, an Automated Diabetic Retinopathy Screening Device
      Diabetes affects approximately 35 million Americans, each of whom needs at least one retinal exam per year. However, majority do not get their eye exam due to multiple prohibitive factors such as cost, transportation, difficulty of taking time off from work, and inconvenience, amongst others. The standard of care in diabetes requires at least an annual eye exam to detect onset of diabetic retinopathy and to treat when indicated. This ...
      Read Full Article
      Mentions: UC Davis FDA RetinAI
    3. RETOUCH: The Retinal OCT Fluid Detection and Segmentation Benchmark and Challenge

      RETOUCH: The Retinal OCT Fluid Detection and Segmentation Benchmark and Challenge
      Retinal swelling due to the accumulation of fluid is associated with the most vision-threatening retinal diseases. Optical coherence tomography (OCT) is the current standard of care in assessing the presence and quantity of retinal fluid and image-guided treatment management. Deep learning methods have made their impact across medical imaging, and many retinal OCT analysis methods have been proposed. However, it is currently not clear how successful they are in interpreting ...
      Read Full Article
    4. 1-5 of 5
  1. Categories

    1. Applications:

      Art, Cardiology, Dentistry, Dermatology, Developmental Biology, Gastroenterology, Gynecology, Microscopy, NDE/NDT, Neurology, Oncology, Ophthalmology, Other Non-Medical, Otolaryngology, Pulmonology, Urology
    2. Business News:

      Acquisition, Clinical Trials, Funding, Other Business News, Partnership, Patents
    3. Technology:

      Broadband Sources, Probes, Tunable Sources
    4. Miscellaneous:

      Jobs & Studentships, Student Theses, Textbooks
  2. About RetinAI

    RetinAI

    RetinAI develops products to make research and health institutions more efficient using latest technologies in machine learning and computer vision. We build software tools to collect, organise and analyse health data from the eyes, empowering communities of healthcare professionals and patients with unique data analysis. We integrate our solutions inside the target server infrastructure and into medical devices, interconnecting the whole clinical pipeline and reducing the time and cost it takes to do clinical and research work, enabling our users to optimise their efforts and to provide a better care. Our vision is to support the transition from reactive to preventive and patient-specific medicine for high-impact diseases in ophthalmology and neurology.